IL6 and hepatocellular carcinoma: The importance of IL-6 signaling in promoting tumorigenesis is well-documented, particularly for tumors associated with chronic inflammation such as colitis-associated colon cancer, pancreatic cancer and hepatocellular carcinoma [36-39].